National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19

被引：2

作者：

Mirenayat, Maryam Sadat ^{[1
]}

Abedini, Atefeh ^{[1
]}

Kiani, Arda ^{[2
]}

Eslaminejad, Alireza ^{[2
]}

Adiminaghan, Parisa ^{[3
]}

Malekmohammad, Majid ^{[2
]}

Heshmatnia, Jalal ^{[4
]}

Nadji, Seyed Alireza ^{[5
]}

Idani, Esmaeil ^{[1
]}

Zahiri, Reyhaneh ^{[1
]}

Lookzadeh, Somayeh ^{[1
]}

Sheikhzade, Hakimeh ^{[4
]}

Dastan, Farzaneh ^{[1
]}

Toutkaboni, Mihan Porabdollah ^{[1
]}

Rezaei, Mitra Sadat ^{[5
]}

Askari, Elham ^{[1
]}

Tabarsi, Payam ^{[4
]}

Marjani, Majid ^{[4
]}

Moniri, Afshin ^{[4
]}

Hashemian, Seyed Mohammad Reza ^{[4
]}

Farzanegan, Behrooz ^{[2
]}

Abtahian, Zahra ^{[4
]}

Yassari, Fatemeh ^{[1
]}

Mansouri, Nazanin ^{[1
]}

Mansouri, Davood ^{[4
]}

Vasheghani, Maryam ^{[1
]}

Mansourafshar, Babak ^{[4
]}

Dezfoli, Mojtaba Mokhber ^{[2
]}

Soleimani, Salman ^{[2
]}

Seifi, Sharareh ^{[1
]}

Naghashzadeh, Farah ^{[6
]}

Fakharian, Atefeh ^{[1
]}

Varahram, Mohammad ^{[7
]}

Jamaati, Hamidreza ^{[1
]}

Zali, Alireza ^{[8
]}

Velayati, Ali Akbar ^{[4
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr CRDRC, Tehran, Iran

[2] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Tracheal Dis Res Ctr, Tehran, Iran

[3] Shahid Beheshti Univ Med Sci, NRITLD, Dept Pulm & Sleep Med, Tehran, Iran

[4] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Clin TB & Epidemiol Res Ctr, Tehran, Iran

[5] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Virol Res Ctr, Tehran, Iran

[6] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Lung Transplantat Res Ctr LTRC, Tehran, Iran

[7] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Mycobacteriol Res Ctr, Tehran, Iran

[8] Shahid Beheshti Univ Med Sci, Res Ctr Neurosurg & Funct Nerves, Tehran, Iran

来源：

IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2022年 / 21卷 / 01期

关键词：

Acute Respiratory Distress Syndrome (ARDS); Coronavirus Disease; Clinical Management; SARS-COV-2; Treatment Guidelines;

D O I：

10.5812/ijpr.123947

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. However, due to the novel nature of the disease and the emergence of new variants, medical teams' updating medical information and drug prescribing guidelines should be given special attention. This version is an updated instruction of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) in collaboration with a group of specialists from Masih Daneshvari Hospital in Tehran, Iran, which is provided to update the information of caring clinicians for the treatment and care of COVID-19 hospitalized patients.

引用

页数：8

共 50 条

[1] Nonspecific Interstitial pneumonia (NSIP)/Overlap or Distinct Entity: A case report from the National Research Institute of Tuberculosis and Lung Disease (NRITLD)
Mehrian, Payam
Cheraghvandi, Ali
Droudnia, Atousa
Talischi, Firouzeh
Tafti, Saeid Fallah
Kahkouee, Shahram
Jamaati, Hamidreza
CASPIAN JOURNAL OF INTERNAL MEDICINE, 2014, 5 (02) : 118 - 122
[2] COVID-19 in Patients with Chronic Lung Disease
Calver, Jessica Fae
Fabbri, Laura
May, James
Jenkins, R. Gisli
CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 385 - 393
[3] OPTIMIZATION OF LUNG CT PROTOCOL FOR THE DIAGNOSTIC EVALUATION OF COVID-19 LUNG DISEASE
Nasab, Seyed Mohammad Bagher Hosseini
Deevband, Mohammad Reza
Rahimi, Roghaye
Nasiri, Saeed
Ahangaran, Mohammad Reza
Morshedi, Mina
RADIATION PROTECTION DOSIMETRY, 2021, 196 (1-2) : 120 - 127
[4] TB-related technical enquiries received at the Research Institute of Tuberculosis, COVID-19
Urakawa, M.
Yasukawa, A.
Hirao, S.
Ota, M.
Hatamoto, Y.
Zama, T.
Nagata, Y.
Yoshiyama, T.
PUBLIC HEALTH ACTION, 2024, 14 (03): : 119 - 123
[5] Tuberculosis treatment-outcome among COVID-19 patients admitted at the Lung Center of the Philippines
Salapante, Katrina Kaye
Magpali, Iris Ayn
Benedicto, Jubert
RESPIROLOGY, 2023, 28 : 106 - 107
[6] Impact of COVID-19 on patients with chronic lung disease
Etel, Etele
Chapman, Taya
Moudgil, Harmesh
Srinivasan, Koottalai
Makan, Annabel
Crawford, Emma
Ahmad, Nawaid
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[7] Factors Associated with Health-Related Quality of Life in Tuberculosis Patients Referred to the National Research Institute of Tuberculosis and Lung Disease in Tehran
Kakhki, Ali Darvishpoor
Masjedi, Mohammad Reza
TUBERCULOSIS AND RESPIRATORY DISEASES, 2015, 78 (04) : 309 - 314
[8] Malignant Mesothelioma in Iranian Patients: A Study from National Institute of Tuberculosis and Lung Disease
Seifi, Sharareh
Khosravi, Adnan
Esfahani-Monfared, Zahra
Salimi, Babak
Khodadad, Klan
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1378 - S1378
[9] Impact of the COVID-19 pandemic on lung cancer treatment and research
Lovlekar, Shreya Kailas
Wang, Yihua
GENES & DISEASES, 2023, 10 (04) : 1217 - 1219
[10] Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
Pietrantonio, Filippo
Morano, Federica
Niger, Monica
Corallo, Salvatore
Antista, Maria
Raimondi, Alessandra
Prisciandaro, Michele
Pagani, Filippo
Prinzi, Natalie
Nichetti, Federico
Randon, Giovanni
Torchio, Martina
Corti, Francesca
Ambrosini, Margherita
Palermo, Federica
Palazzo, Michele
Biamonte, Lavinia
Platania, Marco
Sposito, Carlo
Cosimelli, Maurizio
Mazzaferro, Vincenzo
Pusceddu, Sara
Cremolini, Chiara
de Braud, Filippo
Di Bartolomeo, Maria
CLINICAL COLORECTAL CANCER, 2020, 19 (03) : 156 - 164

← 1 2 3 4 5 →